腹腔B-1b和B-2 B细胞在Prevnar-13接种后提供针对3型肺炎链球菌感染的长期保护,且在镰状细胞病小鼠中缺陷
研究用Prevnar-13间隔三周免疫野生型(WT)和镰状细胞病(SCD)小鼠三次,14周后分离腹腔B-1a、B-1b和B-2细胞过继转移至Rag-/-受体,再用3型肺炎链球菌攻击。接受WT来源B-1b或B-2细胞的受体存活,接受WT来源B-1a细胞的受体死亡;接受SCD来源任一亚型细胞的受体均死亡。
要点
- WT小鼠B-1b或B-2细胞过继转移使受体在3型肺炎链球菌攻击后存活。
- WT小鼠B-1a细胞过继转移的受体在攻击后死亡。
- SCD小鼠B-1a、B-1b或B-2细胞过继转移的受体均死亡。
核心结论
- Prevnar-13接种后B-1b和B-2细胞均似乎提供长期免疫,但这两个亚型在SCD小鼠中均功能缺陷。
研究设计与样本
- 野生型(WT)和镰状细胞病(SCD)小鼠间隔三周接种Prevnar-13三次,14周后分离腹腔B-1a、B-1b和B-2细胞(5×10^4个)腹腔过继转移至Rag-/-受体,一周后以10^3 CFU的3型肺炎链球菌腹腔攻击。
主要发现
- 接受WT小鼠B-1b或B-2细胞的受体小鼠在攻击后存活,接受WT小鼠B-1a细胞的受体小鼠死亡。
- 接受SCD小鼠B-1a、B-1b或B-2细胞的受体小鼠在攻击后均死亡。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Long-term immunity after inoculation with the pneumococcal conjugate vaccine (Prevnar-13) is impaired in sickle cell disease (SCD) mice. We sought to determine which B-cell subsets are defective in SCD mice after vaccination with Prevnar-13, yet confer long-term immunity in wild-type (WT) mice. We vaccinated WT and SCD mice three times at three week intervals with Prevnar-13. Fourteen weeks later, 5∗104 cells of isolated peritoneal B-1a, B-1b, and B-2 cells were harvested and intraperitoneally transferred to Rag -/- recipients. A week later recipients were intraperitoneally challenged with 103CFU of Streptococcus pneumoniae (serotype 3). Recipient mice that received either B-1b or B-2 B-cells from WT mice survived challenge, whereas mice that received B-1a cells died. Recipient mice that received B-1a, B-1b, or B-2 cells from SCD mice died after challenge. Both B-1b and B-2 cells appear to confer long-term immunity after Prevnar-13 vaccination, yet neither subset functions properly in SCD mice.
引用
- Cotte C, Szczepanek SM. Peritoneal B-1b and B-2 B-cells confer long-term protection from pneumococcal serotype 3 infection after vaccination with Prevnar-13 and are defective in sickle cell disease mice. Vaccine. 2017. PMID: 28545925. doi:10.1016/j.vaccine.2017.05.039
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。